Skip to content

Methylphenobarbital

NERVOUS SYSTEM

Also known as: mephobarbital, mephobarbitone, methylphenobarbitone, metylfenemal

YEAR INTRODUCED approvedATC N03AA01

Data last refreshed: (DrugCentral release 2024-11-01)

Key facts

Methylphenobarbital is a drug catalogued in DrugCentral. It was first approved by the YEAR INTRODUCED in 1935. DrugCentral lists 1 molecular target, including GABRA1|GABRG2|GABRB3. Recorded indications include Anxiety, Apprehension, Epilepsy and Tension.

  • Molecular targets: GABRA1|GABRG2|GABRB3 (1 listed in DrugCentral).
  • Indications: Anxiety, Apprehension, Epilepsy, Tension and Tonic-clonic epilepsy.
  • ATC code: N03AA01 (Barbiturates and derivatives).
  • Molecular formula: C13H14N2O3; molecular weight 246.27 g/mol.

Indications & contraindications

Drug–disease relationships curated by DrugCentral (OMOP / SNOMED concepts).

Indications (5)

  • Anxiety
  • Apprehension
  • Epilepsy
  • Tension
  • Tonic-clonic epilepsy

Contraindications (21)

  • Acute exacerbation of asthma
  • Alcoholism
  • Anemia
  • Chronic obstructive lung disease
  • Depressive disorder
  • Disease of liver
  • Hepatic coma
  • Hepatic encephalopathy
  • Hepatic failure
  • Hyperactive behavior
  • Hyperammonemia
  • Kidney disease
  • Neutropenic disorder
  • Porphyria
  • Pregnancy, function
  • Respiratory insufficiency
  • Sleep apnea
  • Sleep automatism
  • Substance abuse
  • Suicidal thoughts
  • Thrombocytopenic disorder

Mechanism & targets

Molecular targets (1)

TargetGeneActionActivity
GABA-A receptor alpha-1/beta-3/gamma-2GABRA1|GABRG2|GABRB3unknown—

Regulatory approvals (1)

DateAgencyMarketed asApplicantOrphan
1935-01-01YEAR INTRODUCED——

ATC classification

ATC codeTherapeutic hierarchy
N03AA01NERVOUS SYSTEM › ANTIEPILEPTICS › ANTIEPILEPTICS › Barbiturates and derivatives

Chemical structure

Full physicochemical, ADMET and 3D-structure analysis of Methylphenobarbital is on its molecule page.

Molecular formulaC13H14N2O3
Molecular weight246.27 g/mol
CAS number115-38-8
InChIKeyALARQZQTBTVLJV-UHFFFAOYSA-N
PubChem CID8271
CCC1(C(=O)NC(=O)N(C)C1=O)C1=CC=CC=C1

Frequently asked questions

Answers are generated from the structured data on this page, not written by hand.

What is Methylphenobarbital used for?

DrugCentral lists the following indications for Methylphenobarbital: Anxiety, Apprehension, Epilepsy, Tension and Tonic-clonic epilepsy.

How does Methylphenobarbital work?

Its molecular targets in DrugCentral include GABRA1|GABRG2|GABRB3.

When was Methylphenobarbital first approved?

Methylphenobarbital was first approved by the YEAR INTRODUCED in 1935.

What is the chemical formula of Methylphenobarbital?

Methylphenobarbital has the molecular formula C13H14N2O3 and a molecular weight of 246.27 g/mol.

Browse: all drugs starting with M · drug guides by category · protein targets A–Z.

Sources

How this page is built: methodology · editorial policy & corrections.

For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.

Quick facts

Status—
First approval1935-01-01
AgencyYEAR INTRODUCED
Targets1
Indications5
FormulaC13H14N2O3
DrugCentral ID1696
Interactive profile